Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging.

Magnetic resonance imaging (MRI), a non-invasive, non-radiative technique, is thought to lead to cellular or even molecular resolution if optimized targeted MR contrast agents are introduced. This would allow diagnosing progressive diseases in early stages. Here, it is shown that the high binding affinity of poly(ethylene glycol)-gallol (PEG-gallol) allows freeze drying and re-dispersion of 9 +/- 2-nm iron oxide cores individually stabilized with approximately 9-nm-thick stealth coatings, yielding particle stability for at least 20 months. Particle size, stability, and magnetic properties of PEGylated particles are compared to Feridex, a commercially available untargeted negative MR contrast agent. Biotin-PEG(3400)-gallol/methoxy-PEG(550)-gallol stabilized nanoparticles are further functionalized with biotinylated human anti-VCAM-1 antibodies using the biotin-neutravidin linkage. Binding kinetics and excellent specificity of these nanoparticles are demonstrated using quartz crystal microbalance with dissipation monitoring (QCM-D). These MR contrast agents can be functionalized with any biotinylated ligand at controlled ligand surface density, rendering them a versatile research tool.

[1]  S. Ylä-Herttuala,et al.  Corrigendum to "Non-invasive Imaging in Gene Therapy". , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  Ralph Weissleder,et al.  Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.

[3]  M. Hove,et al.  Magnetite Fe3O4(111): surface structure by LEED crystallography and energetics , 1994 .

[4]  Etienne Duguet,et al.  Magnetic nanoparticle design for medical applications , 2006 .

[5]  B. Simard,et al.  Surface protected and modified iron based core-shell nanoparticles for biological applications , 2008 .

[6]  G. Sauerbrey,et al.  Use of quartz vibration for weighing thin films on a microbalance , 1959 .

[7]  U. Schwertmann,et al.  Iron Oxides , 2003, SSSA Book Series.

[8]  C. Compton,et al.  Ferrite particles: a new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration. , 1987, The Journal of laboratory and clinical medicine.

[9]  J. Rivas,et al.  Synthesis of monodisperse maghemite nanoparticles by the microemulsion method , 2006 .

[10]  Indraneel Ghosh,et al.  Highly Selective Cyclic Peptide Ligands for NeutrAvidin and Avidin Identified by Phage Display , 2006, Chemical biology & drug design.

[11]  Zahi A. Fayad,et al.  Molecular, cellular and functional imaging of atherothrombosis , 2004, Nature Reviews Drug Discovery.

[12]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[13]  S. Tosatti,et al.  Biomimetic surface modifications based on the cyanobacterial iron chelator anachelin. , 2006, Journal of the American Chemical Society.

[14]  M. Cybulsky,et al.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.

[15]  Chenjie Xu,et al.  Controlled PEGylation of Monodisperse Fe3O4 Nanoparticles for Reduced Non‐Specific Uptake by Macrophage Cells , 2007 .

[16]  Bing Xu,et al.  Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles-a potential candidate for bimodal anticancer therapy. , 2005, Chemical communications.

[17]  E. Teller,et al.  ADSORPTION OF GASES IN MULTIMOLECULAR LAYERS , 1938 .

[18]  A. Gupta,et al.  Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies , 2004, IEEE Transactions on NanoBioscience.

[19]  Michael D Shultz,et al.  Reactive nature of dopamine as a surface functionalization agent in iron oxide nanoparticles. , 2007, Journal of the American Chemical Society.

[20]  A. Berkowitz,et al.  Influence of Crystallite Size on the Magnetic Properties of Acicular γ‐Fe2O3 Particles , 1968 .

[21]  David A. Cheresh,et al.  Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.

[22]  Youjia Cao,et al.  Biocompatible superparamagnetic iron oxide nanoparticle dispersions stabilized with poly(ethylene glycol)-oligo(aspartic acid) hybrids. , 2007, Journal of biomedical materials research. Part A.

[23]  Comparative study of ferrofluids based on dextran-coated iron oxide and metal nanoparticles for contrast agents in magnetic resonance imaging , 2004 .

[24]  Hongjuan Ma,et al.  Facile synthesis of polymer-enveloped ultrasmall superparamagnetic iron oxide for magnetic resonance imaging , 2007, Nanotechnology.

[25]  Ronald W. Barrett,et al.  Peptides Which Bind to E-selectin and Block Neutrophil Adhesion (*) , 1995, The Journal of Biological Chemistry.

[26]  Etienne Duguet,et al.  A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran , 2005 .

[27]  Haeshin Lee,et al.  Mussel-Inspired Surface Chemistry for Multifunctional Coatings , 2007, Science.

[28]  Jon Dobson,et al.  Structural and magnetic properties of nanoscale iron oxide particles synthesized in the presence of dextran or polyvinyl alcohol , 2001 .

[29]  I. Lucet,et al.  Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. , 1996, Journal of microencapsulation.

[30]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[31]  B. Kasemo,et al.  Surface specific kinetics of lipid vesicle adsorption measured with a quartz crystal microbalance. , 1998, Biophysical journal.

[32]  André R Studart,et al.  Colloidal stabilization of nanoparticles in concentrated suspensions. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[33]  R. Ross,et al.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[34]  R. Kornberg,et al.  Two-dimensional crystals of streptavidin on biotinylated lipid layers and their interactions with biotinylated macromolecules. , 1991, Biophysical journal.

[35]  Ralph Weissleder,et al.  Seeing Within: Molecular Imaging of the Cardiovascular System , 2004, Circulation research.

[36]  Diandra L. Leslie-Pelecky,et al.  Magnetic Properties of Nanostructured Materials , 1996 .

[37]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. , 1990, Radiology.

[38]  R Weissleder,et al.  Improvement of MRI probes to allow efficient detection of gene expression. , 2000, Bioconjugate chemistry.

[39]  Bing Xu,et al.  Heterodimers of nanoparticles: formation at a liquid-liquid interface and particle-specific surface modification by functional molecules. , 2005, Journal of the American Chemical Society.

[40]  S. Meiboom,et al.  Modified Spin‐Echo Method for Measuring Nuclear Relaxation Times , 1958 .

[41]  G. Chow,et al.  Carboxyl group (–CO2H) functionalized ferrimagnetic iron oxide nanoparticles for potential bio-applications , 2004 .

[42]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[43]  Fredrik Höök,et al.  Quartz crystal microbalance setup for frequency and Q‐factor measurements in gaseous and liquid environments , 1995 .

[44]  R. Massart,et al.  Preparation of aqueous magnetic liquids in alkaline and acidic media , 1981 .

[45]  Mingyuan Gao,et al.  Preparation of Biocompatible Magnetite Nanocrystals for In Vivo Magnetic Resonance Detection of Cancer , 2006 .

[46]  Anna Roig,et al.  Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[47]  Bing Xu,et al.  Multifunctional yolk-shell nanoparticles: a potential MRI contrast and anticancer agent. , 2008, Journal of the American Chemical Society.

[48]  G. Sauerbrey Verwendung von Schwingquarzen zur Wägung dünner Schichten und zur Mikrowägung , 1959 .

[49]  Bing Xu,et al.  Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. , 2004, Journal of the American Chemical Society.

[50]  Chenjie Xu,et al.  Linking Hydrophilic Macromolecules to Monodisperse Magnetite (Fe(3)O(4)) Nanoparticles via Trichloro-s-triazine. , 2006, Chemistry of materials : a publication of the American Chemical Society.

[51]  P. Messersmith,et al.  Protein resistance of titanium oxide surfaces modified by biologically inspired mPEG-DOPA. , 2005, Langmuir : the ACS journal of surfaces and colloids.